Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Saxenda (liraglutide 3 mg for weight loss) is being phased out by Novo Nordisk globally as the company reallocates manufacturing capacity toward newer GLP-1 medications
If any adverse effects are observed, discontinue use and seek medical advice
The human GLP-1R has an unusually high activation barrier and is essentially silent in the absence of an agonist ligand, relative to other class B GPCRs (e.g
Development of a novel drug delivery system to deliver drugs directly to the colonic mucosa, resulting in improved efficacy and reduced systemic exposure for the treatment of ulcerative colitis
US$ 23.83
US$ 25.99
US$ 25.52
US$ 23.21
US$ 20.42
US$ 21.98
US$ 22.44
US$ 23.91
US$ 26.86
